Boxi Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Boxi Zhang has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Erik Norberg
Department of Physiology and Pharmacology, Solnavägen 9, Biomedicum, Karolinska Institutet, 171 65, Stockholm, Sweden
5 shared publications - Helin Vakifahmetoglu-Norberg
Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, Stockholm, Sweden
5 shared publications Amanda Tomie Ouchida
A Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet , Stockholm , Sweden
3 shared publications- Hazem Khalaf
School of Medical Sciences, Faculty of Medicine and Health, Örebro University, 701 82 Örebro, Sweden
3 shared publications Merve Kacal
Department of Physiology and Pharmacology, Solnavägen 9, Biomedicum, Karolinska Institutet, 171 65, Stockholm, Sweden
3 shared publicationsPer Hydbring
Department of Oncology and Pathology, Karolinska Institutet, 171 64, Stockholm, Sweden
3 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (10) , e70716
Discovery of Epidermal Growth Factor‐Like 7 as a Potential Non‐Invasive Biomarker for Fibrosis and Mortality Risk in MASLD
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a major cause of liver‐related morbidity and mortality worldwide. Although liver biopsy remains the gold standard for assessing fibrosis and predicting outcomes, it is invasive, costly and associated with complications. Therefore, a non‐invasive assessment of fibrosis stage or outcome prediction are urgently needed. In a clinical cohort of 87 patients with biopsy‐confirmed MASLD, we developed a random forest pipeline to determine potential novel biomarkers of interest for the non‐invasive assessment of advanced fibrosis (F3–F4). We investigated the top‐ranked Boruta‐selected biomarker, epidermal growth factor‐like 7 (EGFL7), as a non‐invasive test for advanced fibrosis, using Youden's index to establish a threshold. We performed a Kaplan Meier survival analysis and Cox proportional‐hazards analysis of EGFL7 in a MASLD subpopulation of the UK Biobank to assess its predictive value for all‐cause and liver‐related mortality. This study discovered EGFL7 as a promising candidate for fibrosis classification, achieving 83% accuracy and an AUROC of 0.77. Its diagnostic performance was comparable to FIB‐4. Furthermore, our analysis of a MASLD subpopulation of the UK Biobank revealed that elevated plasma EGFL7 levels were associated with all‐cause mortality ( p < 0.0001) and liver‐related mortality ( p < 0.0001). Cox proportional‐hazards analysis revealed patients with a plasma EGFL7 level above 0.12 had a 51% (HR = 1.51, CI = [1.05–2.17], p = 0.026) higher mortality hazard than those with EGFL7 plasma value below 0.12. Our results suggest that circulating levels of plasma EGFL7 may have utility in the diagnosis and prognosis of patients with MASLD, although these finding do not yet establish EGFL7 as a clinically actionable test.
- 21 September 2026
- Published by Wiley in Clinical and Translational Science
- Vol. 19 (10) , e70716
Open AccessDiscovery of Epidermal Growth Factor‐Like 7 as a Potential Non‐Invasive Biomarker for Fibrosis and Mortality Risk in MASLD
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a major cause of liver‐related morbidity and mortality worldwide. Although liver biopsy remains the gold standard for assessing fibrosis and predicting outcomes, it is invasive, costly and associated with complications. Therefore, a non‐invasive assessment of fibrosis stage or outcome prediction are urgently needed. In a clinical cohort of 87 patients with biopsy‐confirmed MASLD, we developed a random forest pipeline to determine potential novel biomarkers of interest for the non‐invasive assessment of advanced fibrosis (F3–F4). We investigated the top‐ranked Boruta‐selected biomarker, epidermal growth factor‐like 7 (EGFL7), as a non‐invasive test for advanced fibrosis, using Youden's index to establish a threshold. We performed a Kaplan Meier survival analysis and Cox proportional‐hazards analysis of EGFL7 in a MASLD subpopulation of the UK Biobank to assess its predictive value for all‐cause and liver‐related mortality. This study discovered EGFL7 as a promising candidate for fibrosis classification, achieving 83% accuracy and an AUROC of 0.77. Its diagnostic performance was comparable to FIB‐4. Furthermore, our analysis of a MASLD subpopulation of the UK Biobank revealed that elevated plasma EGFL7 levels were associated with all‐cause mortality ( p < 0.0001) and liver‐related mortality ( p < 0.0001). Cox proportional‐hazards analysis revealed patients with a plasma EGFL7 level above 0.12 had a 51% (HR = 1.51, CI = [1.05–2.17], p = 0.026) higher mortality hazard than those with EGFL7 plasma value below 0.12. Our results suggest that circulating levels of plasma EGFL7 may have utility in the diagnosis and prognosis of patients with MASLD, although these finding do not yet establish EGFL7 as a clinically actionable test.
- 8 June 2026
- Published by The R Foundation
OlinkAnalyzeVignettes: Vignettes for Analyzing Data using 'OlinkAnalyze'
Exemplifying analysis of large-scale protein data from the 'Olink platform', primarily relative protein expression data that has been exported from 'Olink NPX Software', as well as QUANT data from 'Olink'. QUANT data is log-transformed. Materials focus on reading data, demonstrating data wrangling and quality control analysis, performing statistical analysis and generating figures to visualize the results of the statistical analysis. The goal of this package is to guide users extract biological insights from large-scale protein data run on the 'Olink platform'. More information on 'Olink' data can be found at .
- 8 June 2026
- Published by The R Foundation
OlinkAnalyzeVignettes: Vignettes for Analyzing Data using 'OlinkAnalyze'
Exemplifying analysis of large-scale protein data from the 'Olink platform', primarily relative protein expression data that has been exported from 'Olink NPX Software', as well as QUANT data from 'Olink'. QUANT data is log-transformed. Materials focus on reading data, demonstrating data wrangling and quality control analysis, performing statistical analysis and generating figures to visualize the results of the statistical analysis. The goal of this package is to guide users extract biological insights from large-scale protein data run on the 'Olink platform'. More information on 'Olink' data can be found at .
- Open Access
Oncogenic ERK signaling represses chaperone-mediated autophagy through transcriptional control of LAMP-2A
Chaperone-mediated autophagy (CMA) is a selective lysosomal degradation pathway governed by the rate-limiting receptor LAMP-2A and increasingly implicated in cancer. However, the oncogenic circuits that enforce CMA repression and whether this state is therapeutically reversible remain unclear. Here, we developed a quantitative bioluminescence-based reporter to measure CMA activity in human cancer cells and combined parallel chemical and genome-scale CRISPR-Cas9 screens to define regulatory pathways. The chemical screen identified GSK1059615 as a CMA-restoring compound that increased LAMP-2A transcription and protein abundance in vitro and in vivo . In parallel, the CRISPR screen revealed ERK signaling as a pathway-level suppressor of CMA. Genetic or pharmacologic ERK inhibition de-repressed LAMP-2A expression, while integrated modulation of ERK, PI3K-AKT, and p38 signaling coordinated transcriptional induction and stabilization of LAMP-2A. Transcriptomic analyses further implicated FOXO1/FOXP1-driven programs in LAMP-2A regulation. Together, these findings position CMA as an integrated output of oncogenic signaling networks and establish a mechanistic framework for restoring CMA activity in defined cancer contexts.
Open AccessOncogenic ERK signaling represses chaperone-mediated autophagy through transcriptional control of LAMP-2A
Chaperone-mediated autophagy (CMA) is a selective lysosomal degradation pathway governed by the rate-limiting receptor LAMP-2A and increasingly implicated in cancer. However, the oncogenic circuits that enforce CMA repression and whether this state is therapeutically reversible remain unclear. Here, we developed a quantitative bioluminescence-based reporter to measure CMA activity in human cancer cells and combined parallel chemical and genome-scale CRISPR-Cas9 screens to define regulatory pathways. The chemical screen identified GSK1059615 as a CMA-restoring compound that increased LAMP-2A transcription and protein abundance in vitro and in vivo . In parallel, the CRISPR screen revealed ERK signaling as a pathway-level suppressor of CMA. Genetic or pharmacologic ERK inhibition de-repressed LAMP-2A expression, while integrated modulation of ERK, PI3K-AKT, and p38 signaling coordinated transcriptional induction and stabilization of LAMP-2A. Transcriptomic analyses further implicated FOXO1/FOXP1-driven programs in LAMP-2A regulation. Together, these findings position CMA as an integrated output of oncogenic signaling networks and establish a mechanistic framework for restoring CMA activity in defined cancer contexts.
- Open Access
- 7 March 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (4) , 747-774
Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors
Tumors often recapitulate programs to acquire invasive and dissemination abilities, during which pro-metastatic proteins are distinctively stabilized in cancer cells to drive further progression. Whether failed protein degradation affects the metastatic programs of cancer remains unknown. Here, we show that the human cancer cell-specific knockout (KO) of LAMP-2A, a limiting protein for chaperone-mediated autophagy (CMA), promotes the aggressiveness of mesenchymal tumors. Deficient CMA resulted in widespread tumor cell dissemination, invasion into the vasculature and cancer metastasis. In clinical samples, metastatic lesions showed suppressed LAMP-2A expression compared to primary tumors from the same cancer patients. Mechanistically, while stimulating TGFβ signaling dampens LAMP-2A levels, genetic suppression of CMA aggravated TGFβ signaling in cancer cells and tumors. Conversely, pharmacological inhibition of TGFβ signaling repressed the growth of LAMP-2A KO-driven tumors. Furthermore, we found that multiple EMT-driving proteins, such as TGFβR2, are degraded by CMA. Our study demonstrates that the tumor suppressive function of CMA involves negative regulation of TGFβ-driven EMT and uncovers a mechanistic link between CMA and a major feature of metastatic invasiveness.
- 7 March 2025
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (4) , 747-774
Open AccessChaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors
Tumors often recapitulate programs to acquire invasive and dissemination abilities, during which pro-metastatic proteins are distinctively stabilized in cancer cells to drive further progression. Whether failed protein degradation affects the metastatic programs of cancer remains unknown. Here, we show that the human cancer cell-specific knockout (KO) of LAMP-2A, a limiting protein for chaperone-mediated autophagy (CMA), promotes the aggressiveness of mesenchymal tumors. Deficient CMA resulted in widespread tumor cell dissemination, invasion into the vasculature and cancer metastasis. In clinical samples, metastatic lesions showed suppressed LAMP-2A expression compared to primary tumors from the same cancer patients. Mechanistically, while stimulating TGFβ signaling dampens LAMP-2A levels, genetic suppression of CMA aggravated TGFβ signaling in cancer cells and tumors. Conversely, pharmacological inhibition of TGFβ signaling repressed the growth of LAMP-2A KO-driven tumors. Furthermore, we found that multiple EMT-driving proteins, such as TGFβR2, are degraded by CMA. Our study demonstrates that the tumor suppressive function of CMA involves negative regulation of TGFβ-driven EMT and uncovers a mechanistic link between CMA and a major feature of metastatic invasiveness.
- 10 February 2022
- Published by The R Foundation
OlinkAnalyze: Facilitate Analysis of Proteomic Data from Olink
- 10 February 2022
- Published by The R Foundation
OlinkAnalyze: Facilitate Analysis of Proteomic Data from Olink
- Open Access
- 20 March 2019
- Published by Taylor & Francis in Autophagy
- Vol. 15 (9) , 1558-1571
Targetome analysis of chaperone-mediated autophagy in cancer cells
Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway of select soluble proteins. Nearly one-third of the soluble proteins are predicted to be recognized by this pathway, yet only a minor fraction of this proteome has been identified as CMA substrates in cancer cells. Here, we undertook a quantitative multiplex mass spectrometry approach to study the proteome of isolated lysosomes in cancer cells during CMA-activated conditions. By integrating bioinformatics analyses, we identified and categorized proteins of multiple cellular pathways that were specifically targeted by CMA. Beyond verifying metabolic pathways, we show that multiple components involved in select biological processes, including cellular translation, was specifically targeted for degradation by CMA. In particular, several proteins of the translation initiation complex were identified as bona fide CMA substrates in multiple cancer cell lines of distinct origin and we show that CMA suppresses cellular translation. We further show that the identified CMA substrates display high expression in multiple primary cancers compared to their normal counterparts. Combined, these findings uncover cellular processes affected by CMA and reveal a new role for CMA in the control of translation in cancer cells. Abbreviations: 6-AN: 6-aminonicotinamide; ACTB: actin beta; AR7: atypical retinoid 7; CHX: cycloheximide; CMA: chaperone-mediated autophagy; CQ: chloroquine; CTS: cathepsins; DDX3X: DEAD-box helicase 3 X-linked; EEF2: eukaryotic translation elongation factor 2; EIF4A1: eukaryotic translation initiation factor 4A1; EIF4H: eukaryotic translation initiation factor 4H; GEO: Gene Expression Omnibus; GO: Gene Ontology; GSEA: gene set enrichment analysis; HK2: hexokinase 2; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; LAMP: lysosomal-associated membrane protein; LDHA: lactate dehydrogenase A; NES: normalized enrichment score; NFKBIA: NFKB inhibitor alpha; PCA: principle component analysis; PQ: paraquat; S.D.: standard deviation; SUnSET: surface sensing of translation; TMT: tandem mass tags; TOMM40/TOM40: translocase of outer mitochondrial membrane 40.
- 20 March 2019
- Published by Taylor & Francis in Autophagy
- Vol. 15 (9) , 1558-1571
Open AccessTargetome analysis of chaperone-mediated autophagy in cancer cells
Chaperone-mediated autophagy (CMA) is a lysosomal degradation pathway of select soluble proteins. Nearly one-third of the soluble proteins are predicted to be recognized by this pathway, yet only a minor fraction of this proteome has been identified as CMA substrates in cancer cells. Here, we undertook a quantitative multiplex mass spectrometry approach to study the proteome of isolated lysosomes in cancer cells during CMA-activated conditions. By integrating bioinformatics analyses, we identified and categorized proteins of multiple cellular pathways that were specifically targeted by CMA. Beyond verifying metabolic pathways, we show that multiple components involved in select biological processes, including cellular translation, was specifically targeted for degradation by CMA. In particular, several proteins of the translation initiation complex were identified as bona fide CMA substrates in multiple cancer cell lines of distinct origin and we show that CMA suppresses cellular translation. We further show that the identified CMA substrates display high expression in multiple primary cancers compared to their normal counterparts. Combined, these findings uncover cellular processes affected by CMA and reveal a new role for CMA in the control of translation in cancer cells. Abbreviations: 6-AN: 6-aminonicotinamide; ACTB: actin beta; AR7: atypical retinoid 7; CHX: cycloheximide; CMA: chaperone-mediated autophagy; CQ: chloroquine; CTS: cathepsins; DDX3X: DEAD-box helicase 3 X-linked; EEF2: eukaryotic translation elongation factor 2; EIF4A1: eukaryotic translation initiation factor 4A1; EIF4H: eukaryotic translation initiation factor 4H; GEO: Gene Expression Omnibus; GO: Gene Ontology; GSEA: gene set enrichment analysis; HK2: hexokinase 2; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; LAMP: lysosomal-associated membrane protein; LDHA: lactate dehydrogenase A; NES: normalized enrichment score; NFKBIA: NFKB inhibitor alpha; PCA: principle component analysis; PQ: paraquat; S.D.: standard deviation; SUnSET: surface sensing of translation; TMT: tandem mass tags; TOMM40/TOM40: translocase of outer mitochondrial membrane 40.
- Open Access
- 19 February 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 2296
Human renal fibroblasts are strong immunomobilizers during a urinary tract infection mediated by uropathogenic Escherichia coli
To prevent the onset of urosepsis and reduce mortality, a better understanding of how uropathogenicEscherichia coli(UPEC) manages to infiltrate the bloodstream through the kidneys is needed. The present study elucidates if human renal interstitial fibroblasts are part of the immune response limiting a UPEC infection, or if UPEC has the ability to modulate the fibroblasts for their own gain. Microarray results showed that upregulated genes were associated with an activated immune response. We also found that chemokines released from renal fibroblasts upon a UPEC infection could be mediated by LPS and triacylated lipoproteins activating the TLR2/1, TLR4, MAPK, NF-κB and PKC signaling pathways. Furthermore, UPEC was also shown to be able to adhere and invade renal fibroblasts, mediated by the P-fimbriae. Furthermore, it was found that renal fibroblasts were more immunoreactive than renal epithelial cells upon a UPEC infection. However, both renal fibroblasts and epithelial cells were equally efficient at inducing neutrophil migration. In conclusion, we have found that human renal fibroblasts can sense UPEC and mobilize a host response with neutrophil migration. This suggests that renal fibroblasts are not only structural cells that produce and regulate the extracellular matrix, but also highly immunoreactive cells.
- 19 February 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 2296
Open AccessHuman renal fibroblasts are strong immunomobilizers during a urinary tract infection mediated by uropathogenic Escherichia coli
To prevent the onset of urosepsis and reduce mortality, a better understanding of how uropathogenicEscherichia coli(UPEC) manages to infiltrate the bloodstream through the kidneys is needed. The present study elucidates if human renal interstitial fibroblasts are part of the immune response limiting a UPEC infection, or if UPEC has the ability to modulate the fibroblasts for their own gain. Microarray results showed that upregulated genes were associated with an activated immune response. We also found that chemokines released from renal fibroblasts upon a UPEC infection could be mediated by LPS and triacylated lipoproteins activating the TLR2/1, TLR4, MAPK, NF-κB and PKC signaling pathways. Furthermore, UPEC was also shown to be able to adhere and invade renal fibroblasts, mediated by the P-fimbriae. Furthermore, it was found that renal fibroblasts were more immunoreactive than renal epithelial cells upon a UPEC infection. However, both renal fibroblasts and epithelial cells were equally efficient at inducing neutrophil migration. In conclusion, we have found that human renal fibroblasts can sense UPEC and mobilize a host response with neutrophil migration. This suggests that renal fibroblasts are not only structural cells that produce and regulate the extracellular matrix, but also highly immunoreactive cells.
- 1 August 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 502 (4) , 429-434
USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2
- 1 August 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 502 (4) , 429-434
USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2
- 1 May 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 499 (2) , 314-320
miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas
- 1 May 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 499 (2) , 314-320
miR-126-5p targets Malate Dehydrogenase 1 in non-small cell lung carcinomas
- Open Access
- 12 June 2017
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 75 (5)
Dual action of bacteriocin PLNC8 αβ through inhibition of Porphyromonas gingivalis infection and promotion of cell proliferation
Periodontitis is a chronic inflammatory disease that is characterised by accumulation of pathogenic bacteria, including Porphyromonas gingivalis, in periodontal pockets. The lack of effective treatments has emphasised in an intense search for alternative methods to prevent bacterial colonisation and disease progression. Bacteriocins are bacterially produced antimicrobial peptides gaining increased consideration as alternatives to traditional antibiotics. We show rapid permeabilisation and aggregation of P. gingivalis by the two-peptide bacteriocin PLNC8 αβ. In a cell culture model, P. gingivalis was cytotoxic against gingival fibroblasts. The proteome profile of fibroblasts is severely affected by P. gingivalis, including induction of the ubiquitin-proteasome pathway. PLNC8 αβ enhanced the expression of growth factors and promoted cell proliferation, and suppressed proteins associated with apoptosis. PLNC8 αβ efficiently counteracted P. gingivalis-mediated cytotoxicity, increased expression of a large number of proteins and restored the levels of inflammatory mediators. In conclusion, we show that bacteriocin PLNC8 αβ displays dual effects by acting as a potent antimicrobial agent killing P. gingivalis and as a stimulatory factor promoting cell proliferation. We suggest preventive and therapeutical applications of PLNC8 αβ in periodontitis to supplement the host immune defence against P. gingivalis infection and support wound healing processes.
- 12 June 2017
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 75 (5)
Open AccessDual action of bacteriocin PLNC8 αβ through inhibition of Porphyromonas gingivalis infection and promotion of cell proliferation
Periodontitis is a chronic inflammatory disease that is characterised by accumulation of pathogenic bacteria, including Porphyromonas gingivalis, in periodontal pockets. The lack of effective treatments has emphasised in an intense search for alternative methods to prevent bacterial colonisation and disease progression. Bacteriocins are bacterially produced antimicrobial peptides gaining increased consideration as alternatives to traditional antibiotics. We show rapid permeabilisation and aggregation of P. gingivalis by the two-peptide bacteriocin PLNC8 αβ. In a cell culture model, P. gingivalis was cytotoxic against gingival fibroblasts. The proteome profile of fibroblasts is severely affected by P. gingivalis, including induction of the ubiquitin-proteasome pathway. PLNC8 αβ enhanced the expression of growth factors and promoted cell proliferation, and suppressed proteins associated with apoptosis. PLNC8 αβ efficiently counteracted P. gingivalis-mediated cytotoxicity, increased expression of a large number of proteins and restored the levels of inflammatory mediators. In conclusion, we show that bacteriocin PLNC8 αβ displays dual effects by acting as a potent antimicrobial agent killing P. gingivalis and as a stimulatory factor promoting cell proliferation. We suggest preventive and therapeutical applications of PLNC8 αβ in periodontitis to supplement the host immune defence against P. gingivalis infection and support wound healing processes.